GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (NYSE:ATR) » Definitions » EV-to-EBITDA
中文

AptarGroup (AptarGroup) EV-to-EBITDA

: 15.43 (As of Today)
View and export this data going back to 1993. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, AptarGroup's enterprise value is $10,245 Mil. AptarGroup's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $664 Mil. Therefore, AptarGroup's EV-to-EBITDA for today is 15.43.

The historical rank and industry rank for AptarGroup's EV-to-EBITDA or its related term are showing as below:

ATR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.9   Med: 13.36   Max: 20.28
Current: 15.43

During the past 13 years, the highest EV-to-EBITDA of AptarGroup was 20.28. The lowest was 8.90. And the median was 13.36.

ATR's EV-to-EBITDA is ranked worse than
51.74% of 489 companies
in the Medical Devices & Instruments industry
Industry Median: 14.89 vs ATR: 15.43

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-23), AptarGroup's stock price is $140.15. AptarGroup's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $4.250. Therefore, AptarGroup's PE Ratio for today is 32.98.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


AptarGroup EV-to-EBITDA Historical Data

The historical data trend for AptarGroup's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AptarGroup Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.66 17.71 15.61 13.56 13.74

AptarGroup Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.56 14.80 14.12 14.29 13.74

Competitive Comparison

For the Medical Instruments & Supplies subindustry, AptarGroup's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AptarGroup EV-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AptarGroup's EV-to-EBITDA falls into.



AptarGroup EV-to-EBITDA Calculation

AptarGroup's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=10245.402/663.837
=15.43

AptarGroup's current Enterprise Value is $10,245 Mil.
AptarGroup's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $664 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AptarGroup  (NYSE:ATR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AptarGroup's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=140.15/4.250
=32.98

AptarGroup's share price for today is $140.15.
AptarGroup's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.250.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


AptarGroup EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AptarGroup's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AptarGroup (AptarGroup) Business Description

Traded in Other Exchanges
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.
Executives
Marc Prieur officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Monnas Giovanna Kampouri director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Sarah Js Glickman director 60 BINNEY STREET, C/O BLUEBIRD BIO, INC., CAMBRIDGE MA 02142
George L Fotiades director 281 SUMMIT AVENUE, SUMMIT NJ 07901
Hedi Tlili officer: Segment President 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Kimberly Chainey officer: EVP and General Counsel 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Xiangwei Gong officer: President, Asia 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60010
Shiela Vinczeller officer: Chief Human Resource Officer 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Julie Xing director 265 EXCHANGE DRIVE, SUITE 301, CRYSTAL LAKE IL 60014
Maritza Gomez Montiel director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Robert Kuhn officer: EVP & CFO C/O APTARGROUP 475 W. TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE IL 60014
Matthew L. Trerotola director 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON DE 19808
Gael Touya officer: Segment President 475 W. TERRA COTTA AVE., SUITE E, CRYSTAL LAKE IL 60014
Candace S. Matthews director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014
Isabel Marey-semper director C/O APTARGROUP, INC., 265 EXCHANGE DRIVE, SUITE 100, CRYSTAL LAKE IL 60014